Labshake search
Citations for Stemcell Technologies :
551 - 600 of 2380 citations for Human Complement Component 1 Q Subcomponent Binding Protein HABP1 C1QBP ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Immunology 2022Quote: ... CD8+ T-cells were negatively isolated from PBMC by magnetic separation using the EasySep Human CD8+ T-Cell Enrichment Kit (Stemcell Technologies; average purity 93%, n=16).
-
bioRxiv - Cancer Biology 2023Quote: ... T cells were then isolated using EasySep™ Human T Cell Isolation Kit and EasySep™ Magnet (Stemcell Technologies, Cat. No. 17951 and Cat. No. 18000) following manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2021Quote: Bone marrows of sacrificed mice were extracted and human cells were separated according to expression of human CD45 (EasySep™, StemCell Technologies, Vancouver, Canada). Libraries were prepared using 10X Genomics technology (see supplemental information).
-
bioRxiv - Immunology 2023Quote: ... 1 mM EDTA) and isolated using a negative isolation kit (EasySep™ Mouse B Cell Isolation Kit, #19854, StemCell Technologies) according to the manufacturer’s instructions ...
-
bioRxiv - Microbiology 2020Quote: Bone marrow-derived primary human CD34+ HSPCs (Stem Cell Technologies) were cultured in erythroid differentiation medium (cPIMDM ...
-
bioRxiv - Genomics 2020Quote: ... CD34+ human cord blood cells were obtained from StemCell Technologies, and long-term CD34+ HSPC cultures were established by overexpression of AML1-ETO or AML1-ETO-FKBP12F36V as previously described23 ...
-
bioRxiv - Molecular Biology 2019Quote: Human primary CD8+ T cells were purchased from STEMCELL Technologies Inc ...
-
bioRxiv - Cancer Biology 2019Quote: ... 20 ng/ml human recombinant epidermal growth factor (StemCell Technologies), 1% Penicillin/Streptomycin (Gibco ...
-
bioRxiv - Bioengineering 2021Quote: ... Human iPS cells were cultured in mTeSR1 (StemCell Technologies; 85870) medium without antibiotics and split (1:6 ...
-
bioRxiv - Microbiology 2020Quote: ... Immunocult human CD3/CD28 T cell activator (STEMCELL Technologies, USA) was used to stimulate the PBMCs as a positive control for immunological activation.
-
bioRxiv - Immunology 2022Quote: ... and recombinant human EGF (10 ug/mL; Stem Cell Technologies) in 10% DMSO before long-term cryopreservation (1X107 cells/mL ...
-
bioRxiv - Microbiology 2020Quote: Commercial Intesticult (INT) human organoid growth medium (Stem Cell Technologies), composed of components A and B ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Human cord blood CD34+ cells were purchased from STEMCELL Technologies GmbH (Cologne ...
-
bioRxiv - Neuroscience 2020Quote: ... Human iPSCs were maintained in complete mTeSR1 medium (STEMCELL Technologies) on Matrigel (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... Primary human peripheral blood CD8+ T cells (Stemcell Technologies - #70027) were expanded using fresh complete ImmunoCult™-XF T Cell Expansion Medium (Stemcell Technologies - #10981 ...
-
bioRxiv - Genetics 2021Quote: ... or ReLeSR Human Pluripotent Stem Cell Passaging Reagent (STEMCELL Technologies), and maintained on media supplemented with the ROCK1 inhibitor Y-27632 (10 µM ...
-
bioRxiv - Cancer Biology 2022Quote: ... Human T cells from anonymous donors sourced by STEMCELL Technologies were isolated by negative selection for CD3+ populations as per manufacturer’s instruction (EasySep ...
-
bioRxiv - Cell Biology 2022Quote: ... and fed with human IntestiCult Organoid Growth Media (STEMCELL technologies). 96 hours after plating ...
-
bioRxiv - Microbiology 2023Quote: ... bone marrow primary human CD34+ HSPCs (Stem Cell Technologies; AllCells) were cultured in PIMDM composed of Iscove Basal Medium (Sigma ...
-
bioRxiv - Immunology 2023Quote: ... Human iPSCs were cultured in mTeSR medium (85852, STEMCELL Technologies) with Matrigel Matrix (354277 ...
-
bioRxiv - Immunology 2023Quote: ... or ImmunoCult Human CD3/CD28 T cell activator (Stemcell Technologies) was added at a dilution of 1:500.
-
bioRxiv - Cancer Biology 2022Quote: ... human bFGF (10 ng/ml, Stem Cell Technologies, cat# 78003) and human EGF (20 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: Human embryonic stem cells were cultured in mTESR (Stemcell technologies) on matrigel (Corning) ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... supplemented with NeuroCult NS-A Proliferation Supplement (human, STEMCELL Technologies), heparin solution (2 mg/mL ...
-
bioRxiv - Biochemistry 2023Quote: ... 10 ng/ml human epidermal growth factor (STEMCELL Technologies, 78006), 20 ng/mL basic fibroblast growth factor (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/ml Human Recombinant GDNF (#78058; Stem Cell Technology), 1 mM Dibutyryl-cAMP (#73882 ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/ml Human Recombinant BDNF (#78005; Stem Cell Technology), 20 ng/ml Human Recombinant GDNF (#78058 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... for direct experimental use or generated in our laboratories from passage-1 human airway epithelial cells (hAEC; obtained from Epithelix SA) using the differentiation protocols and reagents provided by Stemcell Technologies (PneumaCultTM reagent series). In-house generated cultures were derived from three homozygous F508del-CFTR patients ...
-
bioRxiv - Cancer Biology 2023Quote: ... Isolated T cells were seeded at a density of 1 x 106 cells/mL in RPMI medium supplemented with 10 ng/mL human recombinant interleukin 2 (IL2, Stemcell Technologies, Cat. No. 78145.2), 1µg/ml anti-human CD3 antibody (BioLegend ...
-
bioRxiv - Physiology 2019Quote: Monocytes were isolated by the University of Pennsylvania Human Immunology Core from healthy apheresis donors with institutional review board approval by RosetteSep™ human monocyte enrichment cocktail (Stem Cell Technologies, Vancouver, Canada), and MΦs were differentiated by 12-days adherence culture in RPMI 1640 media containing 10% human serum and 1x cell culture pen/strep antibiotic mix (Gibco) ...
-
bioRxiv - Cancer Biology 2021Quote: Human iPSCs were grown in mTeSR or E8 medium (STEMCELL Technologies) as described (17) ...
-
bioRxiv - Molecular Biology 2020Quote: ... and human cytokine cocktail (StemSpan™ CC100, Stemcell Technologies, Cat.No. 02690). The seeded cells were then treated with ...
-
bioRxiv - Molecular Biology 2020Quote: ... and human cytokine cocktail (StemSpan™ CC100, Stemcell Technologies, Cat.No. 02690). The seeded cells were treated with MEISi-1 and MEISi-2 small molecules at 0,1 µM ...
-
bioRxiv - Molecular Biology 2020Quote: Human cells were grown in NeuroCult medium (StemCell Technologies, Vancouver, BC) supplemented with human-EGF at 20 ng/mL and human-bFGF at 20 ng/mL supplemented with penicillin/streptomycin ...
-
bioRxiv - Molecular Biology 2021Quote: ... recombinant human basic FGF (20ng/mL, all from Stem Cell Technologies) and 10 ng/ml laminin (Sigma Aldrich) ...
-
bioRxiv - Bioengineering 2020Quote: Human cord blood or mobilized peripheral blood CD34+ HSCs (StemCell Technologies) were differentiated into enucleated RBCs using a modified version of a previously-described protocol11 ...
-
bioRxiv - Bioengineering 2021Quote: Human peripheral blood cells (PBMCs) were purchased from STEMCELL Technologies (#70025). 100M PBMCs were thawed in 100 mL X-VIVO™ 10 media from Lonza (#04-380Q ...
-
bioRxiv - Immunology 2020Quote: Human peripheral blood mononuclear cells were purchased from Stemcell Technologies (#70025) and CD8+ T cells isolated using the EasySep Human CD8+ T Cell Isolation kit (Stemcell Technologies ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies), 1 mM Dibutyryl-cAMP (PeproTech) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Brain-Derived Neurotrophic Factor (StemCell Technologies), 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies) ...
-
bioRxiv - Immunology 2022Quote: ... and human BAFF46 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Microbiology 2020Quote: ... Human bone marrow CD34+ HPCs were obtained from Stem cell Technologies and recovered in SFEMII (Stem Cell Technologies ...
-
bioRxiv - Immunology 2022Quote: CD34+ cells were isolated from human cord blood (Stemcell Technologies #17896) and cultured for 2 days in expansion media (Miltenyi #130-100-473) ...
-
bioRxiv - Molecular Biology 2021Quote: Human PBMCs were isolated from healthy peripheral whole blood (STEMCELL Technologies) by using gradient method with the Ficoll-Paque (GE Healthcare) ...
-
bioRxiv - Bioengineering 2021Quote: ... additionally supplemented with cytokines (Human Recombinant IL-2; Stemcell Technologies - #78036). To stimulate the cells ...
-
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathologybioRxiv - Neuroscience 2021Quote: ... in combination with RosetteSep Human Monocyte Enrichment Cocktail (StemCell Technologies, #15068) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2020Quote: ... and human BAFF52 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Immunology 2020Quote: ... and Easysep release human biotin positive selection cocktail (17653, STEMCELL Technologies). CD19+CD11c+ B cells (ABCs ...